
Can Semaglutide Cause Headaches?
01Yes, semaglutide can cause headaches as a documented side effect. Clinical trials show headaches occur in 5-14% of patients, typically during the initial weeks of treatment as the body adjusts to the medication.
Long-form guides, side-effect deep-dives, and protocol comparisons for men’s health. No paid posts. No “transform your life” copy. We write what we’d want to read before making a treatment decision — for ourselves or someone in our family. Browse by category, search by keyword, or read everything we’ve published.

Yes, semaglutide can cause headaches as a documented side effect. Clinical trials show headaches occur in 5-14% of patients, typically during the initial weeks of treatment as the body adjusts to the medication.

Tirzepatide does not directly cause hair loss, but rapid weight loss associated with the medication can trigger telogen effluvium, a temporary form of hair shedding that typically occurs 2-4 months after significant weight reduction and usually resolves within 6-9 months.

Current evidence from clinical trials involving over 16,800 patients shows no increased cancer risk from Ozempic in humans. However, the medication carries a black box warning due to thyroid C-cell tumors observed in rodent studies, and it's contraindicated for patients with a personal or family history of medullary thyroid carcinoma.

Semaglutide can be associated with hair loss, though it's not a primary side effect listed in initial clinical trials. The hair loss is typically temporary and linked to rapid weight loss, nutritional deficiencies, and metabolic stress rather than a direct drug effect.

Peptides can be beneficial when used appropriately, as they occur naturally in foods and our bodies, supporting various functions like muscle repair, skin health, and immune function. However, synthetic peptide supplements require medical supervision due to potential side effects and limited long-term safety data.

Current evidence suggests Ozempic does not directly cause depression in most patients, though some post-marketing reports have raised concerns. Clinical trials show no significant increased risk, but individual responses vary and mental health monitoring is recommended during treatment.

Yes, Ozempic can cause hair loss in some users. This side effect is primarily linked to rapid weight loss, nutritional deficiencies, and metabolic changes rather than direct drug toxicity, typically occurring 2-6 months after starting treatment.

No single ED drug is universally "best"—the optimal choice depends on individual factors like onset time preferences, duration needs, side effects, and underlying health conditions. Sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra) are all effective FDA-approved options with different characteristics.

There is no single "best" ED drug for everyone—sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra) are all highly effective PDE5 inhibitors with similar success rates of 70-85%, but they differ in onset time, duration, and side effect profiles, making the optimal choice dependent on individual patient needs, lifestyle, and medical conditions.

Yes, Ozempic can cause tiredness in some patients, though fatigue is relatively uncommon, affecting approximately 0.4% to 11% of users. The fatigue is often related to reduced calorie intake, blood sugar changes, or adjustment periods rather than a direct drug effect.

Peptides are not proteins, though they share the same amino acid building blocks. The key distinction lies in size: peptides typically contain 2-50 amino acids, while proteins consist of 50 or more amino acids arranged in complex three-dimensional structures.

TRT typically does not cause erectile dysfunction (ED) when properly administered to hypogonadal men; it usually improves erectile function. However, improper use, particularly supraphysiological dosing or non-medical testosterone use, can suppress natural testosterone production and potentially worsen ED.
Ready to start a protocol?
Connect with vetted online providers for TRT, GLP-1, ED treatment, and more.
One email a week. The research, not the hype.
What we published, what changed in the evidence, and what it means if you are on a protocol.
No spam, no selling your address. Unsubscribe in one click.